The North Side soon could be home to a state-of-the art growing and processing facility for medical marijuana.

In a complicated transaction, Maryland-based Innovative Industrial Properties, a real estate investment trust focused on the U.S. cannabis market, announced Friday that it had acquired a property in Pittsburgh for about $41.8 million.

While the property wasn’t identified, it is the Northside Commerce Center on Beaver Avenue, formerly owned by the Buncher Co.

In its announcement, Innovative Industrial Properties stated that it was leasing the entire property long term to an affiliate of Parallel, one of the largest cannabis operators in the country, for use as a medical marijuana growing and processing facility.

Advertise with us

At the same time, Florida-based Parallel issued its own announcement, stating that it had sold the warehouse to IIP as part of a sale-leaseback transaction. It valued the deal at $68 million.

It appears that Parallel acquired the company from Buncher and then resold it to Innovative Industrial Properties. Allegheny County real estate records, which are not always up to date, still list Buncher as the owner.

Neither an IIP spokeswoman nor David Heaton, Buncher president and CEO, could be reached for comment.

In its release, Parallel stated that it would use the sale proceeds to complete initial buildout of a Goodblend Pennsylvania “state-of-the-art cannabis growing and processing facility.”

In the first phase, the facility is expected to use 124,000 square feet of space, with another 36,000 available for future expansion. Another 79,000 square feet would be subleased.

Advertise with us

Parallel stated that it hopes to begin operations on the North Side by the middle of the year.

Last August, the Post-Gazette reported that Parallel was planning to develop a cultivation facility in the city as part of a 10-year research agreement with the University of Pittsburgh.

The company is collaborating with Pitt to test its cannabis formulations in the treatment of sickle cell disease and other issues. The university was to receive $3 million in unrestricted grants as part of the deal to investigate the efficacy and safety of medical marijuana.

Pitt is one of eight academic research universities that has been approved to do clinical research as part of the state’s medical marijuana program. Parallel has a state license to grow and process cannabis and to open as many as six retail outlets in Pennsylvania, including one in the Pittsburgh region.

In addition to the growing and processing facility, Parallel stated in its announcement that it intends to open retail locations in Pittsburgh and Erie this year and “will work to identify and open four additional allowed retail” outlets.

Advertise with us

“Completion of our growing and processing facility is an important step as we enter the growing Pennsylvania cannabis market,” said William “Beau” Wrigley Jr., chairman and CEO for Parallel.

“While we were granted our clinical registrant license in the commonwealth in August 2020, which includes a clinical research partnership with the University of Pittsburgh School of Medicine, we now look forward to serving customers at our first Goodblend retail stores in Pittsburgh and Erie, which we intend to open this summer.”

Goodblend is one of Parallel’s retail wellness products and will be used in the Pitt studies.

Parallel and Goodblend Pennsylvania are already hiring for the hundreds of jobs they expect to create in Western Pennsylvania, Elizabeth Conway, Parallel and Goodblend Pennsylvania regional president, said in a statement.

Medical marijuana has become a growing business in the Pittsburgh market.

Advertise with us

According to the Colliers International real estate firm, CannTech PA will use the 143,000-square-foot former Tribune Review printing and distribution plant in Marshall as a medical marijuana growing facility.

Furthermore, Hemp Synergistics has more than doubled its space in Leetsdale to 52,000 square feet, and PurePenn has increased its operations in McKeesport to more than 100,000 square feet, Colliers reported.

Innovative Industrial Properties, meanwhile, owns eight properties in Pennsylvania totaling about 1.1 million square feet and $292.3 million in investment. It also owns and leases to Parallel subsidiaries two regulated cannabis cultivation and processing facilities in Florida and a property in Texas targeted for the same purpose.

Working with medical-use cannabis operators, IIP serves as a source of capital by acquiring and leasing back its real estate assets and offering other “creative real estate-based capital solutions.”

Mark Belko: mbelko@post-gazette.com or 412-263-1262. Post-Gazette reporter Kris Mamula contributed.

Advertise with us